Endoxan 50 mg Tablet

Manufactured by Zydus Cadila
Composition: Cyclophosphamide
Prescription Required: Yes


Endoxan 50 mg Tablet is an anticancer agent which is used in the treatment of various cancers of the blood and the female reproductive system. It should be used under the supervision of a qualified physician. Close monitoring of kidney function and blood cell count is necessary while receiving this medication.


Commonly asked questions for Endoxan 50 mg Tablet

Onset of action

The effect of this medicine can be observed in 2 to 3 hours after an oral dose.

Duration of effect

The effect of this medicine lasts for an average duration of 12 to 24 hours.

Safe with alcohol?

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Is it habit forming?

No habit forming tendency has been reported.

Usage in pregnancy?

This medicine is not recommended for use in pregnant women.

Usage while breast-feeding?

This medicine is not recommended for use in breastfeeding women.


List of substitutes for Endoxan 50 mg Tablet

Below is the list of medicines, which have the same composition, strength and form as Endoxan 50 mg Tablet , and hence can be used as its substitute.


We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.